IRIS
AGAMENNONE, Mariangela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.184
EU - Europa 2.280
AS - Asia 2.265
SA - Sud America 316
AF - Africa 31
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 5
Totale 8.087
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.097
SG - Singapore 898
CN - Cina 638
IT - Italia 465
IE - Irlanda 327
UA - Ucraina 266
BR - Brasile 262
SE - Svezia 252
RU - Federazione Russa 243
GB - Regno Unito 218
VN - Vietnam 218
TR - Turchia 212
DE - Germania 183
IN - India 171
FR - Francia 118
FI - Finlandia 71
CA - Canada 57
GR - Grecia 40
HK - Hong Kong 26
BD - Bangladesh 23
AR - Argentina 18
PL - Polonia 18
MX - Messico 16
JP - Giappone 14
PT - Portogallo 13
ES - Italia 12
IQ - Iraq 12
NL - Olanda 12
EC - Ecuador 11
AT - Austria 10
ID - Indonesia 9
ZA - Sudafrica 9
VE - Venezuela 8
BE - Belgio 7
KR - Corea 7
CZ - Repubblica Ceca 6
EG - Egitto 5
EU - Europa 5
LT - Lituania 5
PK - Pakistan 5
RO - Romania 5
UZ - Uzbekistan 5
CH - Svizzera 4
CI - Costa d'Avorio 4
CL - Cile 4
PY - Paraguay 4
AU - Australia 3
DZ - Algeria 3
IR - Iran 3
KZ - Kazakistan 3
MA - Marocco 3
NI - Nicaragua 3
PE - Perù 3
PH - Filippine 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
BH - Bahrain 2
CO - Colombia 2
HN - Honduras 2
HU - Ungheria 2
IL - Israele 2
JM - Giamaica 2
JO - Giordania 2
MY - Malesia 2
PR - Porto Rico 2
UY - Uruguay 2
AL - Albania 1
BB - Barbados 1
BO - Bolivia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GE - Georgia 1
GY - Guiana 1
KE - Kenya 1
KN - Saint Kitts e Nevis 1
KW - Kuwait 1
LB - Libano 1
LY - Libia 1
MG - Madagascar 1
NP - Nepal 1
PA - Panama 1
PS - Palestinian Territory 1
SC - Seychelles 1
TG - Togo 1
TN - Tunisia 1
TO - Tonga 1
TV - Tuvalu 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.087
Salva come PNG Salva come JPEG
Città #
Singapore 642
San Jose 389
Chandler 334
Jacksonville 333
Dublin 324
Ashburn 248
Dallas 160
Southend 144
Princeton 141
Beijing 139
Nanjing 116
Izmir 107
Chieti 104
Los Angeles 84
Santa Clara 74
Cambridge 72
Ho Chi Minh City 67
Ann Arbor 65
Dearborn 65
Munich 61
Nanchang 55
The Dalles 53
New York 50
Wilmington 48
Tongling 41
Altamura 39
Woodbridge 38
Rome 34
Hanoi 30
Buffalo 28
Hong Kong 26
Redondo Beach 26
Dong Ket 25
São Paulo 25
Shenyang 23
Ottawa 21
Hebei 19
Kunming 19
Moscow 19
San Mateo 19
Orem 18
Tianjin 18
Stockholm 17
Washington 17
Da Nang 16
Jiaxing 16
Milan 16
Nuremberg 16
Atlanta 15
Denver 15
Grevenbroich 15
London 15
Montreal 15
Boardman 14
Toronto 14
Changsha 13
Haiphong 13
Pune 13
Warsaw 13
Hefei 12
Tokyo 12
Brooklyn 11
Ferrara 11
Manchester 11
Norwalk 11
Poplar 11
Porto 11
Andover 10
Rio de Janeiro 10
Turku 10
Augusta 9
Jinan 9
Napoli 9
Pescara 9
Bari 8
Chicago 8
San Francisco 8
Siena 8
Teramo 8
Ankara 7
Belo Horizonte 7
Brussels 7
Council Bluffs 7
Curitiba 7
Hangzhou 7
Houston 7
Johannesburg 7
Leawood 7
Mumbai 7
Ningbo 7
Shanghai 7
Torino 7
Biên Hòa 6
Boston 6
Brasília 6
Brno 6
Changchun 6
Lanzhou 6
Mexico City 6
Naples 6
Totale 4.931
Salva come PNG Salva come JPEG
Nome #
Peptidi della Lattoferrina per uso come inibitori ad ampio spettro dell'infezione da virus dell'influenza 277
Dual targeting of cancer-related human matrix metalloproteinases and carbonic anhydrases by chiral N-(biarylsulfonyl)-phosphonic acids 162
Synthesis and evaluation of new tripeptide phosphonate inhibitors of MMP-8 and MMP-2 156
AMBER force field implementation of the boronate function to simulate the inhibition of beta-lactamases by alkyl and aryl boronic acids 155
Inibitori fosfonati di MMP: Influenza di variazioni strutturali in P3 sulla potenza e sulla selettività d’azione. 153
Derivatives of m-aminophenylboronic acid as ß-lactamases inhibitors. 146
PPARα agonists based on stilbene and its bioisosteres: Biological evaluation and docking studies 145
alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs. 142
Tripeptide Phosphonate Inhibitors of Matrix metalloproteinases. 142
Lactoferrin derived peptides for use as broad- spectrum inhibitors of influenza virus infection 141
Bovine lactoferrin-derived peptides as novel broad-spectrum inhibitors of influenza virus 136
Structural insight into the stereoselective inhibition of MMP-8 by enantiomeric sulphonamide phosphonates 135
Sintesi enantioselettiva di inibitori fosfonati di metalloproteinasi di matrice. 134
Amber* force field implementation to dock alkyl and aryl boronic acids as ß-lactamases inhibitors. 132
Characterization of PD-L1 binding sites by a combined FMO/GRID-DRY approach 132
Sintesi e valutazione biologica di Acidi Aril-Solfonil-Fosfonici come Inibitori selettivi delle Metalloproteinasi di Matrice (MMP). 130
New Matrix Metalloproteinase Inhibitors Based on N-hydroxyurea as zinc-binding group: synthesis, biological evaluation and computational studies. 125
Bisphosfonate matrix metalloproteinase inhibitors for the treatment of periodontitis: An in vitro study 125
Synthesis and biological evaluation of new matrix metalloproteinases inhibitors 124
Synthesis and biological evaluation of new Matrix Metalloproteinases Inhibitors. 124
In vitro comparison of new bisphosphonic acids and zoledronate effects on human gingival fibroblasts viability, inflammation and matrix turnover 124
Catechol-based matrix metalloproteinase inhibitors with additional antioxidative activity 124
Benzothiazole Derivatives Endowed with Antiproliferative Activity in Paraganglioma and Pancreatic Cancer Cells: Structure-Activity Relationship Studies and Target Prediction Analysis 123
VIRTUAL SCREENING APPROACHES FOR THE IDENTIFICATION OF NOVEL NON-ZINC-BINDING MMPs INHIBITORS 122
An Integrated Computational Approach to Rationalize the Activity of Non-Zinc-Binding MMP-2 Inhibitors 121
Amino Acid Derivatives as New Zinc Binding Groups for the Design of Selective Matrix Metalloproteinase Inhibitors 120
Seeking for Non-Zinc-Binding MMP-2 Inhibitors: Synthesis, Biological Evaluation and Molecular Modelling Studies 120
Synthesis and biological evaluation of sulfonyl phosphonic acids as new MMPs inhibitors. 119
Biphenyl Sulfonylamino Methyl Bisphosphonic Acids as Inhibitors of Matrix Metalloproteinases and Bone Resorption 119
In vitro comparison of new bisphosphonic acids and zoledronate effects on human gingival fibroblasts viability, inflammation and matrix turnover 116
Synthesis, SAR and Biological Evaluation of alfa-Sulfonylphosphonic Acid as Selective Matrix Metalloproteinase Inhibitor 115
Bovine lactoferrin prevents influenza a virus infection by interfering with the fusogenic function of viral hemagglutinin 115
N-idrossiuree come inibitori di metalloproteinasi di matrice. 112
Ac‑tLeu‑Asp‑H is the minimal and highly effective human caspase‑3 inhibitor: biological and in silico studies 112
N-Hydroxyurea as zinc binding group in matrix metalloproteinase inhibition: Mode of binding in a complex with MMP-8 111
(2-Aminobenzothiazole)-Methyl-1,1-bisphosphonic acids: Targeting matrix metalloproteinase 13 inhibition to the bone 110
Coumarin-Based Dual Inhibitors of Human Carbonic Anhydrases and Monoamine Oxidases Featuring Amino Acyl and (Pseudo)-Dipeptidyl Appendages: In Vitro and Computational Studies 109
Identification of new anti-Candida compounds by ligand-based pharmacophore virtual screening 108
AMBER force field parameterization for alkyl and aryl boronic acids. 107
Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors 107
Azo derivatives of monoterpenes as anti-Helicobacter pylori agents: from synthesis to structure-based target investigation 106
Bone-Seeking Matrix Metalloproteinase Inhibitors for the Treatment of Skeletal Malignancy 106
Peptidyl 3-substituted 1-hydroxyureas as isosteric analogues of succinylhydroxamate MMP inhibitors 106
Phosphonate Emerging Zinc Binding Group in Matrix Metalloproteinase Inhibitors 105
Probing the S1′ Site for the Identification of Non-Zinc-Binding MMP-2 Inhibitors 102
Fragmenting the S100B–p53 Interaction: CombinedVirtual/Biophysical Screening Approaches to IdentifyLigands 101
Mode of binding of R- and S- sulfonamide phosphonate inhibitors in the active site of MMP-8. 100
An Effective Virtual Screening Protocol to Identify Promising p53-MDM2 Inhibitors 100
synthesis and Activity of Endomorphin-1 and 2 analogues Incorporating Azetidine-(S)-2-carboxylic acid and Azetidine-3-carboxylic acid in place of native proline 99
Effects of Biphenyl Sulfonylamino Methyl Bisphosphonic Acids on Porphyromonas Gingivalis and Cytokine Secretion by Oral Epithelial Cells 99
Fragment-based discovery of S100B inhibitors: when structural information meets in silico prediction. 97
Antiviral Peptides as Anti-Influenza Agents 94
Multiple virtual screening approaches to identify novel, non-hydroxamic class-I HDAC inhibitors. 93
Non-zinc-binding inhibitors of MMP-13: GRID-based approaches to rationalize the binding process 90
Lactoferrin-derived Peptides Active towards Influenza: Identification of Three Potent Tetrapeptide Inhibitors 89
Novel bisphosphonates with antiresorptive effect in bone mineralization and osteoclastogenesis 89
Mimic catechins to develop selective MMP-2 inhibitors 87
Structure-based pharmacophore mapping of flexible macromolecules: targeting the S100B – p53 interaction. 84
Identification of small molecules acting against H1N1 influenza A virus 84
Fragment-based discovery of S100B inhibitors combining computational and biophysical approaches. 82
Benzenesulfonamide derivatives as Vibrio cholerae carbonic anhydrases inhibitors: a computational-aided insight in the structural rigidity-activity relationships 81
Investigation of the N-BP Binding at FPPS by Combined Computational Approaches 81
Matrix metalloproteinases inhibitors, synthesis and biological evaluation. 81
Development of CDK4/6 Inhibitors: A Five Years Update 78
Protein-protein interactions at a glance: Protocols for the visualization of biomolecular interactions 78
Hampering the early aggregation of PrP-E200K protein by charge-based inhibitors: a computational study 78
Fragment-Based Discovery of 5-Arylisatin-Based Inhibitors of Matrix Metalloproteinases 2 and 13 77
Discovery of a novel tetrapeptide against influenza a virus: Rational design, synthesis, bioactivity evaluation and computational studies 69
Virtual screening identification and chemical optimization of substituted 2-arylbenzimidazoles as new non-zinc-binding MMP-2 inhibitors 67
A Comprehensive Computational Insight into the PD-L1 Binding to PD-1 and Small Molecules 61
Broad-Spectrum Activity of Small Molecules Acting against Influenza a Virus: Biological and Computational Studies 61
Resveratrol Analogues as Dual Inhibitors of Monoamine Oxidase B and Carbonic Anhydrase VII: A New Multi-Target Combination for Neurodegenerative Diseases? 60
Identification of Anti-Influenza A Compounds Inhibiting the Viral Non-Structural Protein 1 (NS1) Using a Type I Interferon-Driven Screening Strategy 59
Het(aryl)isatin to het(aryl)aminoindoline scaffold hopping: A route to selective inhibitors of matrix metalloproteinases 59
Erlotinib-containing benzenesulfonamides as anti-Helicobacter pylori agents through carbonic anhydrase inhibition 58
Rational Design of Novel Peptidomimetics against Influenza A Virus: Biological and Computational Studies 54
Discovery of 7-aminophenanthridin-6-one as a new scaffold for matrix metalloproteinase inhibitors with multitarget neuroprotective activity 52
Inhibition of Pseudomonas aeruginosa Carbonic Anhydrases, Exploring Ciprofloxacin Functionalization Toward New Antibacterial Agents: An In-Depth Multidisciplinary Study 50
Inhibition of Human Coronavirus 229E by Lactoferrin-Derived Peptidomimetics 46
Design and Evaluation of Synthesized Pyrrole Derivatives as Dual COX-1 and COX-2 Inhibitors Using FB-QSAR Approach 25
Targeting microbial β-CAs: bridging in silico screening with in vitro validation 22
Discovery and Evaluation of Novel Sulfonamide Derivatives Targeting Aromatase in ER+ Breast Cancer 5
Totale 8.445
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.095
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.095
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021139 0 0 0 0 0 0 0 0 0 57 43 39
2021/2022354 7 7 12 85 27 4 4 21 26 11 46 104
2022/20231.003 98 122 72 91 94 212 59 80 106 13 31 25
2023/2024530 32 20 36 6 28 202 112 7 6 36 6 39
2024/20251.199 56 239 164 10 15 47 25 110 111 68 145 209
2025/20262.626 218 126 331 392 240 155 475 195 327 167 0 0
Totale 8.445